🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very excited to present our group’s research at Queens University, the birthplace of BCG therapy for treatment of non-muscle-invasive bladder cancer (partnership with Dr. John Sfakianos) Matt Galsky Dr. Nina Bhardwaj Lipschultz Precision Immunology Institute The Tisch Cancer Institute Mount Sinai Department of Urology

Immune Cell Context and Treatment Responses: Horowitz Lab @Icahn School of Medicine Mount Sinai, Nina Bhardwaj, and Tahlita Zuiverloon will address this topic in a plenary at the AACR Special Conference on Bladder Cancer (May 17-20, Charlotte, NC). Learn more: bit.ly/3TIftYe #AACRbladder24 Bhardwaj Lab

Join us next week for the International Immunoschool, now in its 9th year. Our theme is 'Challenges & Opportunities in Cancer Immunotherapy' with talks from Eric Vivier Jonathan Kagan Kate Chiappinelli @chiappinellilab.bsky.social Vinod BalachandranMD Kamphorst Lab & more. Register for FREE >>> loom.ly/9no6dhU

Excited to share our new work in Science Immunology! We describe targeting of gut-associated lymphoid tissue (GALT) as a novel mode of action of anti-α4β7 therapy in IBD. Co-led by Mathieu Uzzan & A. Seki Mehandru Lab @MountSinai Lipschultz Precision Immunology Institute Mount Sinai Division of Gastroenterology Icahn School of Medicine at Mount Sinai🧵 science.org/doi/10.1126/sc…

I am so thrilled that our study defining mechanisms of #PerianalFistula in #Crohns disease is now out in Med by Cell Press . Thank you to Judy Cho + team, Mount Sinai IBD Center MountSinai Pathology SinaiMSTP , and the patients who made this possible doi.org/10.1016/j.medj…

Check out the podcast on Science Magazine this week with Miriam Merad, MD, PhD and @IcahnGenomics Director Brian Brown introducing an upcoming supplement on immunology as a frontier of medical research... science.org/content/webina…

Happy to share our new NK cell resource in Nature Immunology: "Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping." nature.com/articles/s4159…. Herman K. Netskar, @AlinePfefferle, Horowitz Lab @Icahn School of Medicine Mount Sinai Human Cell Atlas, Precision Immunotherapy Alliance, UiO - Det medisinske fakultet

Herman K. Netskar @AlinePfefferle Finally, this work accelerated through a great collaboration with the amazing Horowitz Lab @Icahn School of Medicine Mount Sinai and Teichlab and support of the Human Cell Atlas initiative.

Thrilled to announce the publication of our latest research in Nature Immunology. Joining forces with 20 laboratories in Europe and USA, we identified the three prominent NK cell subsets in human: NK1, NK2, and NK3: rdcu.be/dMuAs

Very proud to collaborate with MalmbergLab Herman K. Netskar @AlinePfefferle Teichlab on this brilliant effort to define transcriptional reference mapping of NK cells in healthy & tumor tissues. Framework readily available for all to integrate their own datasets! rdcu.be/dMuQC

Thank you for highlighting our work! We hope this provides support for integrating these ADCs into bladder-sparing treatment approaches for MIBC. Brigham and Women’s Radiation Oncology Dana-Farber Lank Center for Genitourinary Oncology Rebecca Johnson IBCN IBCG

honored to play small role in shaping guidelines for treatment strategies and management of BCG-unresponsive NMIBC under the brilliant efforts of Ashish M. Kamat, MD, MBBS and IBCG Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–... sciencedirect.com/science/articl…

Exciting opportunity for young investigators in #bladdercancer research! BCAN’s Career Development Award is now accepting submissions. This 3-year, $250K grant is your chance to drive innovation and make a lasting impact Bladder Cancer Advocacy Network IBCG

Many congrats @francescacossa1 and Mehandru Lab @MountSinai on a beautiful study!

Wonderful to see this official, John! Very well deserved and excited for you

Please support Alliance A032103 to define the role of ctDNA-based adjuvant therapy decision making in #BladderCancer. Alliance for Clinical Trials in Oncology Bladder Cancer Advocacy Network Uromigos UroToday.com Alan Tan The Tisch Cancer Institute CCTG SWOG Cancer Research Network ECOG-ACRIN Cancer Research Group World Bladder Cancer Patient Coalition

The IBCG Board is excited to announce the new IBCG Center for Patient-Centric Care Initiatives! This global effort will bring together leading experts, patients, and advocates to explore the multifaceted aspects of patient-centric care with a focus on empowering patients,

Very excited to announce partnership with @PurpleBiotech to develop first-in-class tri-specific Abs targeting CD3, NKG2A and TAA. Mechanistic bed-bench approach using patient-derived tumors with a 1st goal of targeting bladder, lung, and HNSCC tumors. purple-biotech.com/press-viewer/?…

So many congrats, John Dr. John Sfakianos and colleagues on the well-deserved recognition!!